Chronic Medical Conditions and CA125 Levels among Women without Ovarian Cancer
Randomized trials using the biomarker cancer antigen (CA) 125, with or without pelvic ultrasound, have failed to show a clear benefit of general population screening for ovarian cancer. In part, this may be due to a lack of information about conditions, besides ovarian cancer, that can alter CA125 l...
Saved in:
Published in | Cancer epidemiology, biomarkers & prevention Vol. 27; no. 12; pp. 1483 - 1490 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.12.2018
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!